1-3 of 3
Elizabeth Apgar, MPH
Close
Sort by
Journal Articles

Hematologic and Hospitalization Outcomes in Patients with Chemotherapy-Induced Anemia (CIA) Treated with Erythropoiesis-Stimulating Agents (ESAs) in the Pre- Vs Post-National Coverage Determination (NCD) Time Periods.

Elizabeth Apgar, MPH, Tanya M. Burton, PhD, Kay Larholt, ScD, Chris L. Pashos, PhD, Lorie Ellis, PhD, MekreĢ Senbetta, PharmD, R. Scott McKenzie, MD
Journal: Blood
Blood (2009) 114 (22): 2482.
https://doi.org/10.1182/blood.V114.22.2482.2482
Published: 2009
Journal Articles

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Tanya Burton, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. Scott Mckenzie, MD
Journal: Blood
Blood (2008) 112 (11): 1301.
https://doi.org/10.1182/blood.V112.11.1301.1301
Published: 2008
Journal Articles

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Tanya Burton, PhD, David Hoaglin, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. scott McKenzie, MD
Journal: Blood
Blood (2008) 112 (11): 1304.
https://doi.org/10.1182/blood.V112.11.1304.1304
Published: 2008